TKPHF:OTCMKTS
Takeda Pharmaceutical Co Ltd
33,85 $
0,00%
(0,00) 1 p
6. okt, 11:51:40 GMT −4 · USD
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse TKPHF põhistatistika genereerimine…
Turu kapit.
58,91 mld
Keskm. maht
2,55 tuh
Maht
0,00
52 näd kõrgeim
39,20 $
52 näd madalaim
26,33 $
Beeta
−2,60
Käibivad aktsiad
1,60 mld
Töötajate arv
47 tuh
Turu kapit.
58,91 mld
Keskm. maht
2,55 tuh
Maht
0,00
52 näd kõrgeim
39,20 $
52 näd madalaim
26,33 $
Beeta
−2,60
Käibivad aktsiad
1,60 mld
Töötajate arv
47 tuh
Uudised
Veebiallikatest ja uudistepartneritelt
AD HOC NEWS
·
9 tunni eest
Takeda Pharmaceutical stock after-hours at EUR 16.55: unchanged
TipRanks
·
11 tunni eest
Takeda’s CDPATH™ Study Signals Growing Focus on Data‑Driven Crohn’s Care
AD HOC NEWS
·
1 päeva eest
Innovent stock gets USD 1.2 billion Takeda oncology deal
Profiil
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
Teave üksuse Takeda Pharmaceutical Co Ltd kohta
TegevjuhtChristophe Weber | Christophe Weber
Töötajad47 tuh
Asutatud12. juuni 1781
Peakontorid-
Sektor-
Veebisaittakeda.com